Jee Technology (688162.SH) has released a profit forecast, expecting a net profit of 16 to 24 million yuan for the year 2024, turning losses into profits.
Juyi Technology (688162.SH) announced that the company expects to achieve net profit attributable to the owners of the parent company in 2024...
Jee Technology (688162.SH) announced that it is expected to achieve a net profit attributable to the owners of the parent company of 16 to 24 million yuan in 2024, compared to a loss in the same period of the previous year, with a year-on-year growth of 107.84% to 111.75%. In 2023, the company's net profit attributable to the owners of the parent company was - 204 million yuan.
Continued investment in research and development and technological innovation have continually improved the company's core competitiveness of its products, with an overall improvement in gross profit margin. The smart equipment business continues to optimize customers and products, resulting in improved profitability of products; the new energy vehicle motor and electronic control component business is expected to see a significant increase in operating income and gross profit margin as some high-end products for major clients begin mass production.
Related Articles

Reebio's testimony: Strong technological barriers coupled with specialized and efficient pipelines, Hong Kong market welcomes scarce innovative drug targets.

New stock news | Jin Xun Group passed the hearing at the Hong Kong Stock Exchange and ranks fifth among China's cathode copper producers.

New Stock News | Jingfeng Medical has passed the hearing of the Hong Kong Stock Exchange and is committed to designing, developing, and manufacturing surgery Siasun Robot&Automation.
Reebio's testimony: Strong technological barriers coupled with specialized and efficient pipelines, Hong Kong market welcomes scarce innovative drug targets.

New stock news | Jin Xun Group passed the hearing at the Hong Kong Stock Exchange and ranks fifth among China's cathode copper producers.

New Stock News | Jingfeng Medical has passed the hearing of the Hong Kong Stock Exchange and is committed to designing, developing, and manufacturing surgery Siasun Robot&Automation.






